Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Ativan (lorazepam) Treatment Report
What is Ativan?

Ativan is a brand name for lorazepam, a benzodiazepine, used in the treatment of anxiety disorders. It is used intravenously for status epilepticus. Off label it is used for alcohol detoxification; insomnia; partial complex seizures; agitation; and as an adjunct in antiemetic treatment.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Anxiety 9 3
Insomnia 4 2
Other 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 25%
Mild
0 0%
None
3 75%

Most commonly reported side effects

Drowsiness
1 25%
  • Mild
  • Moderate
  • Severe

Dosages

  0.5mg as needed 1mg as needed 0.5 mg daily 1 mg daily 1.5 mg daily 2 mg daily 2.5 mg daily
  2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Ativan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
1 100% Other: 100%

See all 1 patient who’ve stopped taking Ativan

Duration See details about how long patients take this treatment ▼

Currently Taking Ativan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
1
2
2

Stopped Taking Ativan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
2 50%
Usually
1 25%
Sometimes
1 25%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 25%
Not at all
3 75%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
3 75%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.